Lovaza
Product Images NDC 80725-420

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lovaza (NDC 80725-420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Waylis Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lovaza 01)

Chemical structure diagram showing a molecule with multiple double bonds and a terminal ethyl ester group, likely representing the active ingredient in Lovaza, an omega-3-acid ethyl ester formulation by Waylis Therapeutics LLC.*

FDA Label Image

Chemical Structure (Lovaza 02)

Chemical structure diagram of the active ingredient in Lovaza, showing the molecular layout of an omega-3 fatty acid ethyl ester compound. The structure includes multiple double bonds and a terminal ethyl ester functional group.*

FDA Label Image

Principal Display Panel (1 gram Bottle Label)

Lovaza (omega-3-acid ethyl esters) Capsules 1 gram. White and orange label with black text showing 120 capsules in the container. Manufactured for Waylis Therapeutics LLC, Rahway, NJ. Includes storage instructions and a barcode on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.